This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 308250 results found since Jan 2013.
COVID-associated complications after reconstructive breast surgery: a retrospective cohort study
ConclusionPerioperative COVID-infection increases susceptibility to complicated wound healing after reconstructive breast surgery. A possible explanation lies in the dysregulation of haemostasis by the virus, and its direct effects on microvasculature. A hypercoagulable state results. We recommend to postpone elective breast surgery for 4 –6 weeks after COVID-19 infection. Also, precautionary measures remain important to minimize the risk of perioperative COVID-19 infection.
Source: Breast Cancer Research and Treatment - September 18, 2023 Category: Cancer & Oncology Source Type: research
Clinical characteristics and prognosis of postpartum breast cancer
ConclusionOur findings indicated that patients diagnosed with breast cancer within the first 5 years after delivery had aggressive characteristics and a poor survival rate. It is important to elucidate the pathophysiology of PPBC and establish novel therapeutic strategies to improve the survival rate.
Source: Breast Cancer Research and Treatment - September 18, 2023 Category: Cancer & Oncology Source Type: research
Ipsilateral breast tumor recurrence after breast-conserving surgery: insights into biology and treatment
AbstractDespite modern surgical and irradiation techniques, ipsilateral breast tumor recurrence (IBTR) accounts for 5 –15% of all cancer recurrence in women treated with breast conservative treatment. Historically, this event has been treated definitively with salvage mastectomy and completion axillary clearance. However, many local recurrences are small and without nodal involvement at presentation. Thus, there has been an interest in performing a surgical de-escalation procedure in the breast and the axilla. The current guidelines do not provide detailed descriptions and treatment suggestions for these selected patient...
Source: Breast Cancer Research and Treatment - September 18, 2023 Category: Cancer & Oncology Source Type: research
ASO Visual Abstract: Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study
Source: Annals of Surgical Oncology - September 18, 2023 Category: Cancer & Oncology Source Type: research
America's breast cancer zip code lottery: Death rates among women vary by up to six-fold between counties in the SAME state
Researchers at George Mason University in Virginia examined county-by-county breast cancer death rates in a new first-of-its kind study.
Source: the Mail online | Health - September 18, 2023 Category: Consumer Health News Source Type: news
Breast Cancer Screening Recommendations for Transgender and Gender Diverse Patients: A Knowledge and Familiarity Assessment of Primary Care Practitioners
AbstractBreast cancer screening recommendations for transgender and gender diverse (TGD) patients have only been recently developed and many primary care practitioners (PCPs) are unaware of these specific recommendations. The aim of this study is to assess the level of familiarity and knowledge PCPs have with breast cancer screening recommendations for TGD patients. An anonymous survey was distributed to primary care physicians, primary care advanced practice practitioners, and internal medicine and family medicine residents at three academic medical systems in the United States (Mayo Clinic, University of Michigan, Univer...
Source: Journal of Community Health - September 18, 2023 Category: International Medicine & Public Health Source Type: research
Cancer Screening Experiences of Black Breast and Ovarian Cancer Patients and Family Members
AbstractBlack women experience disproportionate rates of advanced breast cancer diagnoses and mortality. Mammography is a proven and effective tool in early breast cancer detection and impacts patient outcomes. We interviewed Black women with a personal or family history of breast and/or ovarian cancer to understand their screening experiences and views. N = 61 individuals completed an interview. Interview transcripts were qualitatively analyzed for themes regarding clinical experiences, guideline adherence, and family sharing specific to Black women and their families. Most participants were college educated with act...
Source: Journal of Community Health - September 18, 2023 Category: International Medicine & Public Health Source Type: research
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma Interventions: Drug: Cyclophosphamide; Drug: Docetaxel; Other: Medical Chart Review; Other: Questionnaire Administration Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Use of AI Plus One Radiologist Noninferior for Detecting Breast Cancer
MONDAY, Sept. 18, 2023 -- Double reading of screening mammograms by one radiologist plus artificial intelligence (AI) is noninferior to standard-of-care double reading by two radiologists, according to a study published online Sept. 8 in The Lancet...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news
Erratum to: Comprehensive serum lipidomic analyses reveal potential biomarkers for malignant breast cancer: A case-control study
Cancer Biomark. 2023 Sep 14. doi: 10.3233/CBM-239003. Online ahead of print.NO ABSTRACTPMID:37718782 | DOI:10.3233/CBM-239003
Source: Cancer Biomarkers - September 18, 2023 Category: Cancer & Oncology Source Type: research
